Related Experiment Video
Updated: May 29, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Probiotics for preventing acute upper respiratory tract infections
Qiukui Hao1, Zhenchan Lu, Bi Rong Dong
1Department of Geriatrics, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, China, 610041.
Probiotics significantly reduce the incidence and rate of acute upper respiratory tract infections (URTIs) compared to placebo, with minor side effects. Further research is needed for specific populations like the elderly.
Area of Science:
- Microbiology
- Immunology
- Public Health
Background:
- Probiotics modulate immune function and may prevent respiratory infections.
- Limited evidence exists on probiotic efficacy and safety for acute upper respiratory tract infections (URTIs).
Purpose of the Study:
- To evaluate the effectiveness and safety of probiotics in preventing acute URTIs.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials (RCTs).
- Searched multiple databases including CENTRAL, MEDLINE, EMBASE, and Web of Science.
- Included 14 RCTs, with meta-analysis performed on 10 trials involving 3451 participants.
Main Results:
- Probiotics reduced the number of participants experiencing acute URTI episodes and the overall rate of URTI episodes compared to placebo.
- Antibiotic prescription rates for acute URTIs were lower in the probiotic group.
- No significant difference in the mean duration of URTI episodes or adverse events between probiotics and placebo.
- Probiotic side effects were minor, primarily gastrointestinal.
Conclusions:
- Probiotics demonstrate a beneficial effect in preventing acute URTIs and reducing antibiotic use.
- The findings suggest probiotics may be more effective than placebo for URTI prevention.
- Limitations include heterogeneity in some analyses and lack of data for older adults.
Related Concept Videos
Microbiota of the Respiratory Tract
Probiotics
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...

